{"id":17073,"date":"2026-08-04T09:45:42","date_gmt":"2026-08-04T09:45:42","guid":{"rendered":"https:\/\/nextrove.com\/?p=17073"},"modified":"2026-08-04T09:45:42","modified_gmt":"2026-08-04T09:45:42","slug":"nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations","status":"publish","type":"post","link":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/","title":{"rendered":"Nextrove PACE: Avoiding Overbuilt PV Infrastructure in Emerging and Small Pharma Organizations"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;bottom&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;481527&#8243;][vc_custom_heading text_color=&#8221;color-vyce&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;557846&#8243; text_color_type=&#8221;uncode-palette&#8221;]Avoiding Overbuilt Pharmacovigilance Infrastructure in Early Stages [\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;182916&#8243;]As emerging biotech and small pharma companies progress through clinical development, pharmacovigilance inevitably becomes a growing priority. Regulatory obligations increase, safety oversight becomes more critical, and organizations must demonstrate that they can manage safety activities in a compliant and inspection-ready manner.<\/p>\n<p>The challenge is not whether PV infrastructure is necessary. It is.<\/p>\n<p>The challenge is knowing how much infrastructure is needed today versus what may be needed years from now.<\/p>\n<p>Many early-stage pharma companies \u00a0make the mistake of implementing pharmacovigilance systems and operating models designed for much larger organizations. In an effort to prepare for future growth, they invest in complex platforms, extensive integrations, and enterprise-grade processes long before their business requires them.<\/p>\n<p>The result is often an overbuilt PV environment that creates unnecessary cost, complexity, and operational burden at precisely the stage when agility matters most.[\/vc_column_text][vc_custom_heading text_color=&#8221;color-vyce&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;981393&#8243; text_color_type=&#8221;uncode-palette&#8221;]The Risk of Building for Tomorrow Instead of Today[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;137094&#8243;]Early-stage pharma companies operate in a fundamentally different environment than commercial pharmaceutical organizations.<\/p>\n<p>Teams are lean. Processes are still evolving. Clinical programs change direction. Funding priorities shift. Organizational structures are often built in parallel with product development activities.<\/p>\n<p>In this environment, committing to a large-scale PV infrastructure too early can create friction rather than efficiency.<\/p>\n<p>Many enterprise pharmacovigilance platforms assume:<\/p>\n<ul>\n<li>Mature safety operations<\/li>\n<li>Dedicated internal PV teams<\/li>\n<li>Established case-processing workflows<\/li>\n<li>Significant validation and governance resources<\/li>\n<li>Stable organizational structures<\/li>\n<\/ul>\n<p>Most early-stage pharma have none of these.<\/p>\n<p>Instead, they are often working with small cross-functional teams and outsourced partners while building foundational compliance capabilities. The infrastructure they need should support this reality, \u00a0not assume they have already reached operational maturity.[\/vc_column_text][vc_custom_heading text_color=&#8221;color-vyce&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;146272&#8243; text_color_type=&#8221;uncode-palette&#8221;]Regulatory Readiness Does Not Require Enterprise Complexity[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;440219&#8243;]One of the most common misconceptions in the industry is that regulatory readiness requires enterprise-level systems.<\/p>\n<p>It does not.<\/p>\n<p>Health authorities expect companies to maintain appropriate oversight of safety activities, document their processes, demonstrate compliance, and remain inspection-ready. They do not require organizations to implement the most complex technology available.<\/p>\n<p>In fact, smaller companies can often achieve compliance more effectively through focused, streamlined processes than through large systems that exceed their immediate needs.<\/p>\n<p>The objective should be to establish a pharmacovigilance framework that is proportionate to the organization&#8217;s current stage while maintaining the ability to evolve as requirements become more sophisticated.[\/vc_column_text][vc_custom_heading text_color=&#8221;color-vyce&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;185324&#8243; text_color_type=&#8221;uncode-palette&#8221;]The Hidden Costs of Overbuilding[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;106795&#8243;]The financial investment associated with enterprise PV platforms is often only part of the story.<\/p>\n<p>Beyond licensing costs, organizations frequently encounter:<\/p>\n<ul>\n<li>Lengthy implementation projects<\/li>\n<li>Extensive validation activities<\/li>\n<li>Consulting and professional services fees<\/li>\n<li>Internal training requirements<\/li>\n<li>Ongoing administration and maintenance efforts<\/li>\n<\/ul>\n<p>For resource-constrained biotech and emerging pharma companies, these investments can consume valuable time and capital that could otherwise be directed toward clinical development and operational growth.<\/p>\n<p>More importantly, long implementation cycles delay value. While systems are being configured and deployed, regulatory obligations remain unchanged.<\/p>\n<p>Organizations may spend months preparing for a future-state operating model while immediate compliance needs continue to demand attention.[\/vc_column_text][vc_custom_heading text_color=&#8221;color-vyce&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;640447&#8243; text_color_type=&#8221;uncode-palette&#8221;]Why Flexibility Matters More Than Features[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;120297&#8243;]Emerging biotech and small size organizations growth rarely follows a predictable path.<\/p>\n<p>A financing event, licensing agreement, new clinical study, or regulatory milestone can significantly alter operational requirements in a short period of time.<\/p>\n<p>This unpredictability makes flexibility more valuable than feature depth.<\/p>\n<p>The most effective PV infrastructure for early-stage companies is not necessarily the platform with the largest functionality footprint. It is the solution that can adapt as the organization evolves.<\/p>\n<p>That means:<\/p>\n<ul>\n<li>Supporting outsourced and hybrid operating models<\/li>\n<li>Allowing processes to mature over time<\/li>\n<li>Scaling alongside increasing case volumes<\/li>\n<li>Accommodating organizational growth without requiring major reimplementation<\/li>\n<\/ul>\n<p>The goal is not to avoid growth. The goal is to avoid paying for complexity before it creates value.[\/vc_column_text][vc_custom_heading text_color=&#8221;color-vyce&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;542707&#8243; text_color_type=&#8221;uncode-palette&#8221;]Meet Nextrove PACE: Progressive Adoption and Cloud Evolution[\/vc_custom_heading][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;280817&#8243;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;2&#8243; back_color=&#8221;color-209188&#8243; overlay_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;80&#8243; radius=&#8221;lg&#8221; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; css_animation=&#8221;left-t-right&#8221; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;181927&#8243; back_color_type=&#8221;uncode-palette&#8221; overlay_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_color=&#8221;color-131938&#8243; heading_semantic=&#8221;h1&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;502449&#8243; text_color_type=&#8221;uncode-palette&#8221;]Essentials[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-131938&#8243; heading_semantic=&#8221;h1&#8243; text_size=&#8221;h4&#8243; uncode_shortcode_id=&#8221;639806&#8243; text_color_type=&#8221;uncode-palette&#8221;]Foundation Phase: Start Safely[\/vc_custom_heading][vc_custom_heading text_size=&#8221;h6&#8243; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;163682&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; subheading=&#8221;<\/p>\n<ul>\n<li>Pre-clinical companies<\/li>\n<li>Early clinical programs<\/li>\n<li>Lean biotech teams<\/li>\n<\/ul>\n<p>&#8220;]Ideal for:<br \/>\n[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-jevc&#8221; text_size=&#8221;h6&#8243; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;198927&#8243; text_color_type=&#8221;uncode-palette&#8221; subheading=&#8221;Establish a compliant pharmacovigilance foundation rapidly and cost-effectively, providing the critical infrastructure needed to support early development activities.&#8221;]Core value:[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;2&#8243; back_color=&#8221;color-158149&#8243; overlay_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;70&#8243; radius=&#8221;lg&#8221; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;981008&#8243; back_color_type=&#8221;uncode-palette&#8221; overlay_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_color=&#8221;accent&#8221; heading_semantic=&#8221;h1&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;394641&#8243; text_color_type=&#8221;uncode-palette&#8221;]Efficiencies[\/vc_custom_heading][vc_custom_heading text_color=&#8221;accent&#8221; heading_semantic=&#8221;h1&#8243; text_size=&#8221;h4&#8243; uncode_shortcode_id=&#8221;934066&#8243; text_color_type=&#8221;uncode-palette&#8221;]Acceleration Phase: Automate Intelligently[\/vc_custom_heading][vc_custom_heading text_size=&#8221;h6&#8243; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;517169&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; subheading=&#8221;<\/p>\n<ul>\n<li>Expanding clinical programs<\/li>\n<li>Increasing case volumes<\/li>\n<li>Growing operational demands<\/li>\n<\/ul>\n<p>&#8220;]Ideal for:[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-jevc&#8221; text_size=&#8221;h6&#8243; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;622468&#8243; text_color_type=&#8221;uncode-palette&#8221; subheading=&#8221;Automate workflows, streamline processes, and reduce operational burden while scaling globally through cloud-enabled technologies and intelligent automation.&#8221;]Core value:[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;2&#8243; back_color=&#8221;color-821705&#8243; overlay_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;80&#8243; radius=&#8221;lg&#8221; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; css_animation=&#8221;right-t-left&#8221; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;898947&#8243; back_color_type=&#8221;uncode-palette&#8221; overlay_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_color=&#8221;color-976181&#8243; heading_semantic=&#8221;h1&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;202345&#8243; text_color_type=&#8221;uncode-palette&#8221;]Excellence[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-976181&#8243; heading_semantic=&#8221;h1&#8243; text_size=&#8221;h4&#8243; uncode_shortcode_id=&#8221;523358&#8243; text_color_type=&#8221;uncode-palette&#8221;]Enterprise Readiness Phase: Scale Strategically[\/vc_custom_heading][vc_custom_heading text_size=&#8221;h6&#8243; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;101485&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; subheading=&#8221;<\/p>\n<ul>\n<li>Late-stage biotech organizations<\/li>\n<li>Commercialization readiness<\/li>\n<li>Marketed product portfolios<\/li>\n<\/ul>\n<p>&#8220;]Ideal for:[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-jevc&#8221; text_size=&#8221;h6&#8243; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;294500&#8243; text_color_type=&#8221;uncode-palette&#8221; subheading=&#8221;Achieve operational excellence through a fully integrated, AI-powered pharmacovigilance ecosystem capable of supporting global compliance and long-term growth.&#8221;]Core value:[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_custom_heading text_color=&#8221;color-vyce&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;199841&#8243; text_color_type=&#8221;uncode-palette&#8221;]What Early-Stage Companies Should Prioritize[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;140394&#8243;]Rather than pursuing enterprise-scale pharmacovigilance environments, early-stage organizations should focus on building a strong operational foundation.<\/p>\n<p>That foundation typically includes:<\/p>\n<p><strong>Clear Safety Processes<\/strong><\/p>\n<p>Well-defined procedures for case intake, assessment, reporting, and oversight.<\/p>\n<p><strong>Inspection Readiness<\/strong><\/p>\n<p>Documented responsibilities, governance structures, and evidence of compliance activities.<\/p>\n<p><strong>Efficient Technology<\/strong><\/p>\n<p>Systems that support operational execution without creating unnecessary administrative burden.<\/p>\n<p><strong>Flexible Service Models<\/strong><\/p>\n<p>The ability to leverage outsourced expertise while maintaining appropriate sponsor oversight.<\/p>\n<p><strong>Scalable Architecture<\/strong><\/p>\n<p>Infrastructure that can grow as clinical programs, products, and regulatory obligations expand.<\/p>\n<p>These capabilities provide the rigor required by regulators while preserving the agility needed by emerging companies.<\/p>\n<p><strong>PACE (Progressive Adoption and Cloud Evolution) <\/strong>provides the right-sized approach to PV<\/p>\n<p>Nextrove PACE aligns with the emerging and small pharma organizations current needs while creating a practical path for future growth.<\/p>\n<p>Nextrove PACE allows companies to:<\/p>\n<ul>\n<li>Achieve compliance quickly<\/li>\n<li>Maintain inspection readiness<\/li>\n<li>Minimize operational burden<\/li>\n<li>Control costs<\/li>\n<li>Scale efficiently as the business evolves<\/li>\n<\/ul>\n<p>Most importantly, it enables organizations to focus resources on advancing their products rather than managing unnecessary system complexity.[\/vc_column_text][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;208605&#8243;][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text uncode_shortcode_id=&#8221;946236&#8243;]By combining simplicity, speed, and scalability, PACE helps companies establish regulatory readiness, optimize operations, and seamlessly evolve into enterprise-grade pharmacovigilance without the disruption, cost, or complexity of rebuilding systems as they grow<\/p>\n<h2>PACE: Where Safety Meets Simplicity.<\/h2>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; back_color=&#8221;accent&#8221; overlay_alpha=&#8221;50&#8243; radius=&#8221;std&#8221; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;263158&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_button size=&#8221;btn-lg&#8221; border_width=&#8221;0&#8243; link=&#8221;url:mailto%3Ainfo%40nextrove.com|target:_blank&#8221; uncode_shortcode_id=&#8221;117781&#8243;]Request a Meeting[\/vc_button][\/vc_column_inner][\/vc_row_inner][vc_separator sep_color=&#8221;color-vyce&#8221; uncode_shortcode_id=&#8221;945272&#8243; sep_color_type=&#8221;uncode-palette&#8221;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Meet Nextrove PACE, the scalable pharmacovigilance ecosystem that grows with your journey, from early development to enterprise readiness.<\/p>\n","protected":false},"author":1,"featured_media":17074,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[79],"tags":[],"class_list":["post-17073","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nextrove PACE: Progressive Adoption and Cloud Evolution<\/title>\n<meta name=\"description\" content=\"Meet Nextrove PACE, the scalable pharmacovigilance ecosystem that grows with your journey, from early development to enterprise readiness.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/\" \/>\n<meta property=\"og:locale\" content=\"ko_KR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Accelerating Transformation Success with Expert Change Management\" \/>\n<meta property=\"og:description\" content=\"Digital transformation initiatives can fail when not strategically guided. At Nextrove, change management is built into our Business Transformation framework to ensure a tangible, lasting impact.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/\" \/>\n<meta property=\"og:site_name\" content=\"Nextrove\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-04T09:45:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nextrove.com\/wp-content\/uploads\/2025\/06\/Nextrove_Articles_20250714_BusinessTransformation02.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\uae00\uc4f4\uc774\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"\uc608\uc0c1 \ub418\ub294 \ud310\ub3c5 \uc2dc\uac04\" \/>\n\t<meta name=\"twitter:data2\" content=\"6\ubd84\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/#\\\/schema\\\/person\\\/537142fb2f0051496524c2a926802eab\"},\"headline\":\"Nextrove PACE: Avoiding Overbuilt PV Infrastructure in Emerging and Small Pharma Organizations\",\"datePublished\":\"2026-08-04T09:45:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/\"},\"wordCount\":1758,\"image\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nextrove.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/20260804-PACE2.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"ko-KR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/\",\"url\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/\",\"name\":\"Nextrove PACE: Progressive Adoption and Cloud Evolution\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nextrove.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/20260804-PACE2.jpg\",\"datePublished\":\"2026-08-04T09:45:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/#\\\/schema\\\/person\\\/537142fb2f0051496524c2a926802eab\"},\"description\":\"Meet Nextrove PACE, the scalable pharmacovigilance ecosystem that grows with your journey, from early development to enterprise readiness.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/#breadcrumb\"},\"inLanguage\":\"ko-KR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ko-KR\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nextrove.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/20260804-PACE2.jpg\",\"contentUrl\":\"https:\\\/\\\/nextrove.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/20260804-PACE2.jpg\",\"width\":1536,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nextrove PACE: Avoiding Overbuilt PV Infrastructure in Emerging and Small Pharma Organizations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/#website\",\"url\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/\",\"name\":\"Nextrove\",\"description\":\"Empowering Clients to Improve Patient Safety\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ko-KR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/#\\\/schema\\\/person\\\/537142fb2f0051496524c2a926802eab\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ko-KR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/nextrove.com\\\/ko\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nextrove PACE: Progressive Adoption and Cloud Evolution","description":"Meet Nextrove PACE, the scalable pharmacovigilance ecosystem that grows with your journey, from early development to enterprise readiness.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/","og_locale":"ko_KR","og_type":"article","og_title":"Accelerating Transformation Success with Expert Change Management","og_description":"Digital transformation initiatives can fail when not strategically guided. At Nextrove, change management is built into our Business Transformation framework to ensure a tangible, lasting impact.","og_url":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/","og_site_name":"Nextrove","article_published_time":"2026-08-04T09:45:42+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/nextrove.com\/wp-content\/uploads\/2025\/06\/Nextrove_Articles_20250714_BusinessTransformation02.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\uae00\uc4f4\uc774":"admin","\uc608\uc0c1 \ub418\ub294 \ud310\ub3c5 \uc2dc\uac04":"6\ubd84"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/#article","isPartOf":{"@id":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/"},"author":{"name":"admin","@id":"https:\/\/nextrove.com\/ko\/#\/schema\/person\/537142fb2f0051496524c2a926802eab"},"headline":"Nextrove PACE: Avoiding Overbuilt PV Infrastructure in Emerging and Small Pharma Organizations","datePublished":"2026-08-04T09:45:42+00:00","mainEntityOfPage":{"@id":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/"},"wordCount":1758,"image":{"@id":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/#primaryimage"},"thumbnailUrl":"https:\/\/nextrove.com\/wp-content\/uploads\/2026\/08\/20260804-PACE2.jpg","articleSection":["News"],"inLanguage":"ko-KR"},{"@type":"WebPage","@id":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/","url":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/","name":"Nextrove PACE: Progressive Adoption and Cloud Evolution","isPartOf":{"@id":"https:\/\/nextrove.com\/ko\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/#primaryimage"},"image":{"@id":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/#primaryimage"},"thumbnailUrl":"https:\/\/nextrove.com\/wp-content\/uploads\/2026\/08\/20260804-PACE2.jpg","datePublished":"2026-08-04T09:45:42+00:00","author":{"@id":"https:\/\/nextrove.com\/ko\/#\/schema\/person\/537142fb2f0051496524c2a926802eab"},"description":"Meet Nextrove PACE, the scalable pharmacovigilance ecosystem that grows with your journey, from early development to enterprise readiness.","breadcrumb":{"@id":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/#breadcrumb"},"inLanguage":"ko-KR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/"]}]},{"@type":"ImageObject","inLanguage":"ko-KR","@id":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/#primaryimage","url":"https:\/\/nextrove.com\/wp-content\/uploads\/2026\/08\/20260804-PACE2.jpg","contentUrl":"https:\/\/nextrove.com\/wp-content\/uploads\/2026\/08\/20260804-PACE2.jpg","width":1536,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/nextrove.com\/ko\/nextrove-pace-avoiding-overbuilt-pv-infrastructure-in-emerging-and-small-pharma-organizations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nextrove.com\/ko\/"},{"@type":"ListItem","position":2,"name":"Nextrove PACE: Avoiding Overbuilt PV Infrastructure in Emerging and Small Pharma Organizations"}]},{"@type":"WebSite","@id":"https:\/\/nextrove.com\/ko\/#website","url":"https:\/\/nextrove.com\/ko\/","name":"Nextrove","description":"Empowering Clients to Improve Patient Safety","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nextrove.com\/ko\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ko-KR"},{"@type":"Person","@id":"https:\/\/nextrove.com\/ko\/#\/schema\/person\/537142fb2f0051496524c2a926802eab","name":"admin","image":{"@type":"ImageObject","inLanguage":"ko-KR","@id":"https:\/\/secure.gravatar.com\/avatar\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/nextrove.com\/ko\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/posts\/17073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/comments?post=17073"}],"version-history":[{"count":1,"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/posts\/17073\/revisions"}],"predecessor-version":[{"id":17078,"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/posts\/17073\/revisions\/17078"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/media\/17074"}],"wp:attachment":[{"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/media?parent=17073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/categories?post=17073"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nextrove.com\/ko\/wp-json\/wp\/v2\/tags?post=17073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}